Search results
Results from the WOW.Com Content Network
JD-3 laser dazzler on Type 99A tank. The dazzler can be seen at the top-right, located behind the gunner thermal sight. Weapons designed to cause permanent blindness are banned by the 1995 United Nations Protocol on Blinding Laser Weapons. Dazzlers intended to cause temporary blindness or disorientation fall outside this protocol. [citation needed]
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
Dazer Lasers use a "GreenStar Laser" (US Patent and Trademark Office provisional patent application no. 61/348,312), which is a diode-pumped solid-state (DPSS), 532 nm (green), Class IIIb laser that produces maximum power of over 750 mW without having to increase the same laser's size. [4]
For treating atopic dermatitis, newer (second generation) corticosteroids, such as fluticasone propionate and mometasone furoate, are more effective and safer than older ones. They are also generally safe and do not cause skin thinning when used intermittently to treat atopic dermatitis flare-ups.
The personnel halting and stimulation response rifle (PHASR) is a prototype non-lethal laser dazzler developed by the Air Force Research Laboratory's Directed Energy Directorate, U.S. Department of Defense. [1] Its purpose is to temporarily disorient and blind a target.
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
The methasones (or metasones) are a class of corticosteroids [1] which are generally used in dermatology.They are defined by substitution with a methyl group at the C16α or C16β position of the pregnane steroid nucleus.
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]